VANCOUVER, Jan. 20 /CNW/ - Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Corporation") is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for reducing phytic acid in the production of protein isolates from oilseed meals. A notice of allowance from the United States Patent and Trademark Office is a written notification that a patent application has cleared internal review and is nearing issuance.
Phytic acid is a naturally occurring anti-nutritional component found in oilseed meals such as canola meal and soybean meal. There is concern that, due to the strong cation binding capacity, high levels of phytic acid in the diet may decrease the bioavailability of essential minerals such as calcium, magnesium, zinc and iron, and thus impact mineral nutrition (Anderson et al. 1976; Jones, 1979; Larsen & Samdstrom, 1992; Weaver & Kannan, 2002). Phytates may also form complexes with proteins, interfering with their utilization (Hidvegi & Lasztity, 2002). For these reasons, Burcon conducted research into methods for reducing the level of phytate in the vegetable protein isolates produced from Burcon's protein extraction processes. The notice of allowance now received from the United States Patent and Trademark Office covers those processes.
"This most recent notice of allowance from the United States Patent Office is valuable as it covers important processing conditions for producing protein isolates from oilseed meals with improved nutritional characteristics," said Johann F. Tergesen, President and Chief Operating Officer, adding, "These patented processing techniques allow for Burcon's CLARISOY(TM), a revolutionary soy protein isolate as well as Puratein(R) and Supertein(TM) canola protein isolates to have a superior nutritional profile which opens up opportunities for their use in a wider spectrum of nutritional products and in additional food and beverage applications."
To-date, Burcon's patent portfolio consists of 107 issued patents in various countries, including 12 issued U.S. patents, and in excess of 200 additional pending patent applications, 67 of which are U.S. patent applications. Five of Burcon's 67 U.S. patent applications have now been allowed, including the patent allowance which is the subject of this news release, and will be issued as granted U.S. patents in the near future.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing Puratein(R) and Supertein(TM) canola protein isolates with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 107 issued patents in various countries, including 12 issued U.S. patents, and in excess of 200 additional pending patent applications, 67 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
Burcon NutraScience Corporation is a publicly listed on the Toronto Stock Exchange under the symbol "BU". For more information on Burcon, visit www.burcon.ca.
This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, the Corporation's, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal", "intend", "believes", "potential", "expected", "anticipates", "will be", and similar expressions, generally identify forwardlooking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.
SOURCE Burcon NutraScience Corporation
For further information: For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free, firstname.lastname@example.org, www.burcon.ca; AXINO AG, Wolfgang Seybold, Investor Relations Europe, AXINO AG, Königstrasse 26, 70173 Stuttgart, Germany, Tel. +49-711-25 35 92-40, Fax +49-711-25 35 92-55, email@example.com, www.burcon.net